Security record · archived quarter
IXJ
iShares Global Healthcare ETF · Financial Services · Asset Management - Global
5Tracked holders
—Δ holders
4.87MShares held
$452.13MReported value
+0New positions
−0Exits
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 60 | +1 | 22.16M | $2.18B | +5 | −4 |
| Q1 2026 | 60 | 0 | 20.98M | $1.96B | +3 | −3 |
| Q4 2025 | 60 | 0 | 28.75M | $2.80B | +1 | −1 |
| Q3 2025 | 10 | +2 | 22.95M | $2.03B | +2 | — |
| Q2 2025 | 5 | +2 | 21.02M | $1.81B | +2 | — |
| Q1 2025 | 1 | -4 | 7.29M | $665.20M | — | −4 |
| Q4 2024 | 5 | 0 | 5.45M | $468.21M | +1 | −1 |
| Q3 2024 | 5 | 0 | 5.26M | $516.38M | — | — |
| Q2 2024 | 5 | — | 4.87M | $452.13M | — | — |
Who holds it · Q2 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fisher Asset Management ✦ | 4.85M | — | $449.81M | 0.2% | n/c | 1 | SEC ↗ |
| 2 | Marshall Wace ✦ | 12.32K | — | $1.14M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Renaissance Technologies ✦ | 6.30K | — | $584,892 | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Citadel Advisors ✦ | 3.25K | — | $301,544 | 0.0% | n/c | 1 | SEC ↗ |
| 5 | D. E. Shaw & Co. ✦ | 3.13K | — | $290,496 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 281 holders, 26.34M shares, $2.46B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q2 2024 ·
Methodology ·
Get this via the API